Safety of remdesivir in COVID-19 patients: post-marketing evaluation on spontaneous adverse event reporting system

Cesaro, M.; Rafaniello, C.; Di Mauro, C.; Zinzi, A.; Ferrajolo, C.; Scavone, C.; Sportiello, L.; Sullo, M.; Rossi, F.; Capuano, A.

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Safety of remdesivir in COVID-19 patients: post-marketing evaluation on spontaneous adverse event reporting system

Cesaro, M.; Rafaniello, C.; Di Mauro, C.; Zinzi, A.; Ferrajolo, C.; Scavone, C.; Sportiello, L.; Sullo, M.; Rossi, F.; Capuano, A..

European Journal of Clinical Pharmacology ; 78(SUPPL 1):S116-S117, 2022.

Article in English | Web of Science | ID: covidwho-1912929

Keywords

Pharmacology & Pharmacy

Search on Google

Print

XML

Collection: Databases of international organizations Database: Web of Science Type of study: Experimental Studies Language: English Journal: European Journal of Clinical Pharmacology Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Print

XML

Collection: Databases of international organizations Database: Web of Science Type of study: Experimental Studies Language: English Journal: European Journal of Clinical Pharmacology Year: 2022 Document Type: Article